Last reviewed · How we verify
Interferon-Gamma — Competitive Intelligence Brief
marketed
Lymphocyte Growth Factor [EPC]
Small molecule
Live · refreshed every 30 min
Target snapshot
Interferon-Gamma (Interferon-Gamma) — SPP Pharmaclon Ltd..
Comparator set (5 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Interferon-Gamma TARGET | Interferon-Gamma | SPP Pharmaclon Ltd. | marketed | Lymphocyte Growth Factor [EPC] | ||
| Citomix | INTERFERON | Bayer Healthcare Pharms | marketed | Lymphocyte Growth Factor [EPC] | 2015-01-01 | |
| Proleukin | ALDESLEUKIN | Chiron | marketed | Lymphocyte Growth Factor [EPC] | Interleukin-2 receptor | 1992-01-01 |
| Cranberry | Cranberry | University of British Columbia | marketed | Lymphocyte Growth Factor [EPC] | ||
| Guna-Virus | METENKEFALIN | Guna spa | marketed | Lymphocyte Growth Factor [EPC] | ||
| Citomix | BINETRAKIN | Guna spa | marketed | Lymphocyte Growth Factor [EPC] |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Lymphocyte Growth Factor [EPC] class)
- Guna spa · 2 drugs in this class
- Bayer Healthcare Pharms · 1 drug in this class
- Chiron · 1 drug in this class
- SPP Pharmaclon Ltd. · 1 drug in this class
- University of British Columbia · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Interferon-Gamma CI watch — RSS
- Interferon-Gamma CI watch — Atom
- Interferon-Gamma CI watch — JSON
- Interferon-Gamma alone — RSS
- Whole Lymphocyte Growth Factor [EPC] class — RSS
Cite this brief
Drug Landscape (2026). Interferon-Gamma — Competitive Intelligence Brief. https://druglandscape.com/ci/interferon-gamma. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab